Celcuity
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.About CELC
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.
CEOBrian F. Sullivan
CEOBrian F. Sullivan
Employees87
Employees87
HeadquartersMinneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded2012
Founded2012
Employees87
Employees87
CELC Key Statistics
Market cap2.29B
Market cap2.29B
Price-Earnings ratio-15.23
Price-Earnings ratio-15.23
Dividend yield—
Dividend yield—
Average volume927.02K
Average volume927.02K
High today$54.76
High today$54.76
Low today$51.72
Low today$51.72
Open price$52.44
Open price$52.44
Volume635.65K
Volume635.65K
52 Week high$63.06
52 Week high$63.06
52 Week low$7.58
52 Week low$7.58
CELC News
Simply Wall St 1d
The Bull Case For Celcuity Could Change Following Expanded Credit Facility and Rising Commercial AmbitionsCelcuity Inc. was recently added to the S&P Biotechnology Select Industry Index and announced an amended senior secured credit facility that expands its total t...
TipRanks 3d
Celcuity initiated with a Buy at GuggenheimGuggenheim initiated coverage of Celcuity (CELC) with a Buy rating and $110 price target Published first on TheFly – the ultimate source for real-time, market-...
Simply Wall St 3d
Celcuity: Evaluating Valuation After FDA Nod for Gedatolisib and Financial Facility ExpansionCelcuity (CELC) just made headlines with a flurry of news that is hard to ignore if you're weighing your next move. The company not only received FDA acceptance...
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.